PCRX 8-K 2026-01-08

Pacira BioSciences, Inc. (PCRX) 8-K dated 2026-01-08 — accession 0001628280-26-001335. This URL is the filing, not the PCRX hub.

Pacira BioSciences, Inc. (PCRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.

Pacira BioSciences, Inc. filed a 8-K on 2026-01-08. Accession 0001628280-26-001335.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported PCRX revenue for 2026-06-30 was $369.8M. Net income was $7.6M. PCRX currently screens at market cap $890.8M and trailing P/E 174.2.

Not investment advice. The PCRX SEC hub lists recent forms. The stock page is the research view.